Benjamin Sorg
Overview
Explore the profile of Benjamin Sorg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Bielack S, Blattmann C, Borkhardt A, Csoka M, Hassenpflug W, Kabickova E, et al.
Eur J Cancer
. 2022 Oct;
176:50-57.
PMID: 36191386
Purpose: Most aspects of osteosarcoma have been addressed in detail, but there is no comprehensive analysis of deceased patients and causes of death. Methods: The database of the Cooperative Osteosarcoma...
12.
Hecker-Nolting S, Baumhoer D, Blattmann C, Kager L, Kuhne T, Kevric M, et al.
J Cancer Res Clin Oncol
. 2022 Aug;
149(5):1961-1967.
PMID: 35980483
Purpose: The course of osteosarcoma patients primarily treated as such has been well described. Little, however, is known about patients who were primarily treated assuming a different tumor diagnosis. Methods:...
13.
Kube S, Blattmann C, Bielack S, Kager L, Kaatsch P, Kuhne T, et al.
Cancer
. 2022 Feb;
128(9):1787-1800.
PMID: 35195899
Background: Increased survival in young sarcoma patients comes along with a higher incidence of second malignant neoplasms (SMNs). The incidence, latency, histiotype, and outcome of these patients were analyzed because...
14.
Gotta J, Bielack S, Hecker-Nolting S, Sorg B, Kevric M, Salzmann-Manrique E, et al.
Klin Padiatr
. 2021 Dec;
234(3):154-162.
PMID: 34902872
Background: Increasing numbers of patients surviving malignant bone tumors around the knee joint have led to an increasing importance to investigate long-term results. This study assessed the long-term results of...
15.
Sparber-Sauer M, Vokuhl C, Seitz G, Sorg B, Tobias M, von Kalle T, et al.
Pediatr Blood Cancer
. 2021 Oct;
69(3):e29403.
PMID: 34636137
Background: Infantile myofibromatosis (IM) is a rare benign soft tissue tumor and often a self-limiting disease but rarely includes life-threatening complications. Little is known about optimal treatment of primary localized...
16.
Sparber-Sauer M, Tagarelli A, Seitz G, Sorg B, Bien E, Bel-Ami T, et al.
Pediatr Blood Cancer
. 2021 Sep;
68(12):e29268.
PMID: 34486213
Background: Children with progressive (PD) or relapsed disease (RD) of pleuropulmonary blastoma (PPB) type II/III are known to have a very poor outcome. Methods: A retrospective review of children registered...
17.
Langer T, Clemens E, Broer L, Maier L, Uitterlinden A, de Vries A, et al.
Data Brief
. 2020 Sep;
32:106227.
PMID: 32939381
Genetic association studies suggest a genetic predisposition for cisplatin-induced ototoxicity. Among other candidate genes, thiopurine methyltransferase () is considered a critical gene for susceptibility to cisplatin-induced hearing loss in a...
18.
Langer T, Clemens E, Broer L, Maier L, Uitterlinden A, de Vries A, et al.
Eur J Cancer
. 2020 Sep;
138:212-224.
PMID: 32905960
Background: Irreversible sensorineural hearing loss is a common side effect of platinum treatment with the potential to significantly impair the neurocognitive, social and educational development of childhood cancer survivors. Genetic...
19.
Ferrari S, Bielack S, Smeland S, Longhi A, Egerer G, Hall K, et al.
Tumori
. 2017 Dec;
104(1):30-36.
PMID: 29218692
Introduction: The EUROpean Bone Over 40 Sarcoma Study (EURO-B.O.S.S.) was the first prospective international study for patients 41-65 years old with high-grade bone sarcoma treated with an intensive chemotherapy regimen...